Reid Hoffman-linked entity reports VOR sales; 1,278,118 shares held
Rhea-AI Filing Summary
Vor Biopharma (VOR) insider filing reports open‑market sales by an affiliate of director Reid Hoffman totaling 96,657 shares across 10/10–10/14/2025, executed at weighted average prices disclosed in the filing. Following these transactions, 1,278,118 shares were beneficially owned.
The securities are held by Reprogrammed Interchange LLC; Mr. Hoffman may be deemed a beneficial owner through shared control and indirect pecuniary interest and disclaims beneficial ownership except to the extent of his interest. The filing was made by more than one reporting person.
Positive
- None.
Negative
- None.
Insights
Director-affiliated entity sold 96,657 VOR shares; 1,278,118 remain.
This Form 4 lists multiple open‑market sales over several days, each reported with weighted average prices and footnoted price ranges. Such filings document changes in insider-affiliated holdings and the remaining beneficial ownership after the trades.
The shares are held by Reprogrammed Interchange LLC, with Reid Hoffman potentially deemed a beneficial owner via shared control; he disclaims beneficial ownership except for his pecuniary interest. Actual market impact depends on trade size relative to float and daily volume, which are not provided in the excerpt.
Subsequent ownership stands at 1,278,118 shares after the reported sales. Any further activity would appear in future ownership reports if and when filed.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Sale | Common Stock | 33,668 | $30.3192 | $1.02M |
| Sale | Common Stock | 19,672 | $32.3587 | $637K |
| Sale | Common Stock | 2,334 | $33.0873 | $77K |
| Sale | Common Stock | 40,983 | $30.9673 | $1.27M |
Footnotes (1)
- This transaction was executed in multiple trades at prices ranging from $30.68 to $31.29. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price. The securities are held by Reprogrammed Interchange LLC ("Reprogrammed"). Reid Hoffman may be deemed a beneficial owner of securities held by Reprogrammed by virtue of his shared control over and indirect pecuniary interest in Reprogrammed. Mr. Hoffman disclaims beneficial ownership of the securities held by Reprogrammed, except to the extent of his pecuniary interest therein. This transaction was executed in multiple trades at prices ranging from $32.00 to $32.98. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price. This transaction was executed in multiple trades at prices ranging from $33.00 to $33.135. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price. This transaction was executed in multiple trades at prices ranging from $30.00 to $30.86. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price.
FAQ
What is the beneficial ownership after the reported VOR trades?
Who holds the reported VOR securities?
Were the VOR sales executed in multiple trades?
Was the Form 4 filed by more than one reporting person?
On which dates did the VOR insider sales occur?